These Are The Billionaire Investors Behind German Drugmakers Developing A Coronavirus Vaccine - Forbes

One of Germany’s wealthiest software tycoons is the biggest shareholder in CureVac, a company racing to develop a coronavirus vaccine. Two billionaire biotech investors are also behind BioNTech, which announced it’s developing a vaccine.

Continue reading...